These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19051240)

  • 21. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of intestinal absorption blockade in hypercholesterolemia treatment].
    Diz-Lois F
    Rev Clin Esp; 2004 Oct; 204(10):554-60. PubMed ID: 15456613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multi-center, open label, crossover designed prospective study evaluating the effects of lipid lowering treatment on steroid synthesis in patients with Type 2 diabetes (MODEST Study).
    Kanat M; Serin E; Tunckale A; Yildiz O; Sahin S; Bolayirli M; Arinc H; Dirican A; Karagoz Y; Altuntas Y; Celebi H; Oguz A
    J Endocrinol Invest; 2009 Nov; 32(10):852-6. PubMed ID: 19783896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome.
    Jimenez JG; Rosen JB; Pirags V; Massaad R; Hanson ME; Brudi P; Triscari J
    Diabetes Obes Metab; 2013 Jun; 15(6):513-22. PubMed ID: 23279632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.
    Goldberg RB; Guyton JR; Mazzone T; Weinstock RS; Polis A; Edwards P; Tomassini JE; Tershakovec AM
    Mayo Clin Proc; 2006 Dec; 81(12):1579-88. PubMed ID: 17165637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
    Athyros VG; Tziomalos K; Kakafika AI; Koumaras H; Karagiannis A; Mikhailidis DP
    Am J Cardiol; 2008 Feb; 101(4):483-5. PubMed ID: 18312762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intensive cholesterol lowering therapy to reduce cardiovascular risk].
    Rigotti R A; Arteaga Ll A; Maiz G A
    Rev Med Chil; 2006 May; 134(5):641-8. PubMed ID: 16802058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy.
    Ali M; Mehmood A; Anjum MS; Tarrar MN; Khan SN; Riazuddin S
    Mol Cell Biochem; 2015 Dec; 410(1-2):267-79. PubMed ID: 26359087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus.
    Jaumdally RJ; Goon PK; Varma C; Blann AD; Lip GY
    J Intern Med; 2010 Apr; 267(4):385-93. PubMed ID: 19754853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased levels of circulating endothelial progenitor cells in patients with ischaemic stroke treated with statins during acute phase.
    Sobrino T; Blanco M; Pérez-Mato M; Rodríguez-Yáñez M; Castillo J
    Eur J Neurol; 2012 Dec; 19(12):1539-46. PubMed ID: 22640405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
    Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
    Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A statin for a patient with hyperlipidemia and hepatitis C?
    Nash DT
    Postgrad Med; 2004 May; 115(5):86. PubMed ID: 15171081
    [No Abstract]   [Full Text] [Related]  

  • 33. Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.
    Sodha NR; Boodhwani M; Ramlawi B; Clements RT; Mieno S; Feng J; Xu SH; Bianchi C; Sellke FW
    J Card Surg; 2008; 23(4):312-20. PubMed ID: 18598320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S; Turco S; Guarino G; Sasso CF; Amodio M; Magliano P; Salvatore T; Corigliano G; Agrusta M; De Simone G; Gaeta I; Oliviero B; Torella R
    Diabetes Obes Metab; 2000 Dec; 2(6):355-62. PubMed ID: 11225965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease.
    Leiter LA; Bays H; Conard S; Bird S; Rubino J; Hanson ME; Tomassini JE; Tershakovec AM
    Am J Cardiol; 2008 Dec; 102(11):1495-501. PubMed ID: 19026303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
    Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
    J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.
    Tabuchi T; Satoh M; Itoh T; Nakamura M
    Clin Sci (Lond); 2012 Aug; 123(3):161-71. PubMed ID: 22364258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study.
    Derdemezis C; Filippatos T; Tselepis A; Mikhailidis D; Elisaf M
    Expert Opin Pharmacother; 2008 Aug; 9(11):1829-37. PubMed ID: 18627322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK.
    Bao XM; Wu CF; Lu GP
    Atherosclerosis; 2010 May; 210(1):114-21. PubMed ID: 20018284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.